SERPING1 and hereditary angioedema: According to the latest WAO-EAACI 2022 guidelines for hereditary angioedema, four treatments are indicated for LTP in patients with HAE-C1INH: berotralstat, lanadelumab, and subcutaneous or intravenous plasma-derived C1INH concentrates.